Lung Cancer

1

Editorial Board

Journal:

Lung Cancer

Year:

2006

Language:

english

File:

PDF, 33 KB

english, 2006

2

Hedgehog signaling in small-cell lung cancer: Frequent in vivo but a rare event in vitro

Vestergaard, Janni, Pedersen, Mikkel W., Pedersen, Nina, Ensinger, Christian, Tümer, Zeynep, Tommerup, Niels, Poulsen, Hans Skovgaard, Larsen, Lars Allan

Journal:

Lung Cancer

Year:

2006

Language:

english

File:

PDF, 999 KB

english, 2006

4

Results of a Phase II study of weekly docetaxel and carboplatin in Stage IIIB (with effusion) or Stage IV non-small cell lung cancer patients age ≤65 and performance status 2

Weissman, Charles H., Sandbach, John, Brooker, Reginald, Vellek, Mark, Lindquist, Deborah, Conkling, Paul, Ilegbodu, Des, Asmar, Lina

Journal:

Lung Cancer

Year:

2006

Language:

english

File:

PDF, 98 KB

english, 2006

5

Lung cancer with chest wall involvement: Predictive factors of long-term survival after surgical resection

Voltolini, Luca, Rapicetta, Cristian, Luzzi, Luca, Ghiribelli, Claudia, Ligabue, Tommaso, Paladini, Piero, Gotti, Giuseppe

Journal:

Lung Cancer

Year:

2006

Language:

english

File:

PDF, 247 KB

english, 2006

6

Matrix metalloproteinase-13 expression is associated with bone marrow microinvolvement and prognosis in non-small cell lung cancer

Hsu, Chung-Ping, Shen, Gwan-Han, Ko, Jiunn-Liang

Journal:

Lung Cancer

Year:

2006

Language:

english

File:

PDF, 256 KB

english, 2006

7

Results of surgery in small cell carcinoma of the lung

de Antonio, David Gómez, Alfageme, Fernando, Gámez, Pablo, Córdoba, Mar, Varela, Andrés

Journal:

Lung Cancer

Year:

2006

Language:

english

File:

PDF, 133 KB

english, 2006

8

A phase II trial of gemcitabine plus UFUR combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy

Chen, Yuh-Min, Perng, Reury-Perng, Tsai, Chun-Ming, Whang-Peng, Jacqueline

Journal:

Lung Cancer

Year:

2006

Language:

english

File:

PDF, 146 KB

english, 2006

9

Analysis of c-kit expression in small cell lung cancer: Prevalence and prognostic implications

Camps, Carlos, Sirera, Rafael, Bremnes, Roy M., Garde, Javier, Safont, María José, Blasco, Ana, Berrocal, Alfonso, Sánchez, José Javier, Calabuig, Consuelo, Martorell, Miguel

Journal:

Lung Cancer

Year:

2006

Language:

english

File:

PDF, 194 KB

english, 2006

10

Secondary cancers after a lung carcinoid primary: A population-based analysis

Cote, M.L., Wenzlaff, A.S., Philip, P.A., Schwartz, A.G.

Journal:

Lung Cancer

Year:

2006

Language:

english

File:

PDF, 112 KB

english, 2006

11

Third-line chemotherapy for small cell lung cancer

de Jong, Wouter K., ten Hacken, Nick H.T., Groen, Harry J.M.

Journal:

Lung Cancer

Year:

2006

Language:

english

File:

PDF, 138 KB

english, 2006

12

Phase II study of pegylated liposomal doxorubicin HCl (Caelyx) in combination with cyclophosphamide and vincristine as second-line treatment of patients with small cell lung cancer

Leighl, Natasha B., Goss, G.D., Lopez, P.G., Burkes, R.L., Dancey, J.E., Rahim, Y.H., Rudinskas, L.C., Pouliot, J.F., Rodgers, A., Pond, G.R., Shepherd, F.A.

Journal:

Lung Cancer

Year:

2006

Language:

english

File:

PDF, 168 KB

english, 2006

13

10.1016/j.lungcan.2006.03.001

Garfield, D.

Journal:

Lung Cancer

Year:

2006

Language:

english

File:

PDF, 59 KB

english, 2006

14

A phase I/II trial of weekly docetaxel and gefitinib in elderly patients with stage IIIB/IV non-small cell lung cancer

Stinchcombe, Thomas E., Bůžková, Petra, Choksi, Janak, Taylor, Mark, Bakri, Kamal, Gillenwater, Heidi, Tynan, Maureen, Mears, Andrea, Jones, Paul E., Socinski, Mark A.

Journal:

Lung Cancer

Year:

2006

Language:

english

File:

PDF, 133 KB

english, 2006

15

Peptide ligands targeting integrin α3β1 in non-small cell lung cancer

Lau, Derick, Guo, Linlang, Liu, Ruiwu, Marik, Jan, Lam, Kit

Journal:

Lung Cancer

Year:

2006

Language:

english

File:

PDF, 263 KB

english, 2006

16

A randomized phase II trial evaluating standard (50mg/min) versus low (10mg/min) infusion duration of gemcitabine as first-line treatment in advanced non-small-cell lung cancer patients who are not eligible for platinum-based chemotherapy

Cappuzzo, F., Novello, S., De Marinis, F., Selvaggi, G., Scagliotti, G.V., Barbieri, F., Maur, M., Papi, M., Pasquini, E., Bartolini, S., Marini, L., Crinò, L.

Journal:

Lung Cancer

Year:

2006

Language:

english

File:

PDF, 167 KB

english, 2006

17

Cost-minimization analysis for Portugal of five doublet chemotherapy regimens from two phase III trials in the treatment of advanced non-small cell lung cancer

Pimentel, F.L., Bhalla, S., Laranjeira, L., Guerreiro, M.

Journal:

Lung Cancer

Year:

2006

Language:

english

File:

PDF, 277 KB

english, 2006

18

Primary surgery revisited in very limited small cell lung cancer: Does it have a role?

Sorensen, Morten

Journal:

Lung Cancer

Year:

2006

Language:

english

File:

PDF, 71 KB

english, 2006

19

Estimated impact of LDCT-identified stage IA non-small-cell lung cancer on screening efficacy

Reich, Jerome M.

Journal:

Lung Cancer

Year:

2006

Language:

english

File:

PDF, 155 KB

english, 2006

Volume 52; Issue 3

Editorial Board

Contents

Hedgehog signaling in small-cell lung cancer: Frequent in vivo but a rare event in vitro

Results of a Phase II study of weekly docetaxel and carboplatin in Stage IIIB (with effusion) or Stage IV non-small cell lung cancer patients age ≤65 and performance status 2

Lung cancer with chest wall involvement: Predictive factors of long-term survival after surgical resection

Matrix metalloproteinase-13 expression is associated with bone marrow microinvolvement and prognosis in non-small cell lung cancer

Results of surgery in small cell carcinoma of the lung

A phase II trial of gemcitabine plus UFUR combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy

Analysis of c-kit expression in small cell lung cancer: Prevalence and prognostic implications

Secondary cancers after a lung carcinoid primary: A population-based analysis

Third-line chemotherapy for small cell lung cancer

Phase II study of pegylated liposomal doxorubicin HCl (Caelyx) in combination with cyclophosphamide and vincristine as second-line treatment of patients with small cell lung cancer

10.1016/j.lungcan.2006.03.001

A phase I/II trial of weekly docetaxel and gefitinib in elderly patients with stage IIIB/IV non-small cell lung cancer

Peptide ligands targeting integrin α3β1 in non-small cell lung cancer

A randomized phase II trial evaluating standard (50mg/min) versus low (10mg/min) infusion duration of gemcitabine as first-line treatment in advanced non-small-cell lung cancer patients who are not eligible for platinum-based chemotherapy

Cost-minimization analysis for Portugal of five doublet chemotherapy regimens from two phase III trials in the treatment of advanced non-small cell lung cancer

Primary surgery revisited in very limited small cell lung cancer: Does it have a role?

Estimated impact of LDCT-identified stage IA non-small-cell lung cancer on screening efficacy